Combining heartburn drugs and aspirin could prevent oesophageal cancer in people at high risk

June 5, 2018 by Justine Alford, Cancer Research UK
Combining heartburn drugs and aspirin could prevent oesophageal cancer in people at high risk
Credit: Flickr/CC BY-NC-ND 2.0

In the famous words of Benjamin Franklin: "An ounce of prevention is worth a pound of cure."

While he may have been talking about fire safety rather than disease, this sentiment rings true for too. If there was a way to stop cancer from developing, then the stress, costs and side effects that come with a diagnosis and treatment could be avoided.

The challenge is that not all cancers are preventable, and there's no elixir of life to help us get around the biggest risk factor for the disease – getting older. But some can be prevented – around 4 in 10 in the UK – meaning there's an opportunity to act and help reduce the burden of the disease.

For cancers where survival remains poor, like oesophageal cancer, there's potential to make the greatest difference for people. That's why many of our scientists are working in this area, and new research showcases the progress they're making.

A new Cancer Research UK-funded clinical trial has found that two over-the-counter, widely available drugs could help cut cases of oesophageal cancer in people at higher risk of the disease. And when these drugs – a stomach acid blocker and aspirin – were used together, their effects were even greater.

"We weren't expecting such overwhelmingly positive data," says lead author Prof Janusz Jankowski from the Royal College of Surgeons in Ireland, who is presenting the findings at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

"The drugs caused a reduction in overall death and oesophageal cancers. It really surprised us how big the effect was, the effect for strong acid prevention was 4 times higher than we expected."

Questions remain, such as who might benefit most from these drugs, and can they specifically prevent deaths from oesophageal cancer? But the findings mark an important step towards progress against a disease that has lagged others.

Risk and reason

Oesophageal cancer begins in the (oesophagus). The disease often doesn't cause clear symptoms during its early stages, meaning many cases are diagnosed late when they've spread and become difficult to treat. That's one of the main reasons why survival for oesophageal cancer is stubbornly low, with just over 1 in 10 people surviving their disease for a decade or longer.

It's time for this grim situation to be turned around, and our researchers are showing that's possible.

This latest study centres on one of the risk factors for oesophageal cancer, a condition called Barrett's oesophagus. This is where the cells that line the food pipe change from a layered, brick wall to looking more like a picket fence. Normally, this happens because of stomach acid making its way up the food pipe (acid reflux) and damaging the cells.

Over time, these cells can become so different to healthy cells that they turn cancerous. This only happens to between 1 and 5 people in every 100 with Barrett's oesophagus, but with acid reflux on the rise, there's an opportunity to intervene and make a difference.

Mining for gold

For the study, scientists wanted to find out whether giving people with Barrett's oesophagus a drug – called a proton pump inhibitor (PPI) – to treat their could prevent their condition from worsening, and cut cases of oesophageal cancer. They also wanted to test whether adding aspirin could have a beneficial effect too.

Working across the UK and Canada, the team recruited more than 2,557 adults with Barrett's oesophagus and randomly assigned them one of four treatments every day:

  • A high dose of PPI with aspirin
  • A high dose of PPI without aspirin
  • A low dose of PPI with aspirin
  • A low dose of PPI without aspirin

These people were then followed for an average of 9 years, amounting to a mammoth 20,000 years of patient data.

"It's the longest of its kind in terms of follow up," says Jankowski. "And no one had ever looked at combining PPIs and aspirin before for cancer prevention. That's meant it's been building a real gold mine for data collection."

When they dug into this data gold mine, they found that high dose PPI treatment not only reduced progression of people's Barrett's oesophagus, but cases of oesophageal cancer and the number of people dying from any cause were lower too. And when aspirin was added in to the mix, the effect was even greater.

"We were expecting PPI treatment to maybe reduce cases of oesophageal cancer by about 5%," says Jankowski.

"But we found the reduction was more like 20% in people given a high daily dose, which took us all by shock."

Importantly, the drugs seemed to be safe too, with very few people experiencing side effects. But this is an important concern with using drugs to prevent cancer in this way, particularly aspirin, which is linked with bleeding risks when used long-term.

A case for change

So, what is it about this combination that seems to be so effective? While PPIs work by taming the cells' environment, making it less hostile from the , aspirin is thought to have a calming effect on growing cells.

"If we imagine a cell as a car careeing down a motorway, aspirin is like a speed regulator. It slows down cell metabolism and generally dampens down 'go' signals that could accelerate growth," explains Jankowski.

"Whereas PPIs are like the truck that sprays grit on the road surface, making it less likely that the car will skid out of control when conditions become unfavourable."

And with such encouraging results, Jankowski doesn't think it will be long before the findings will hopefully start helping people outside of clinical trials.

"There's no question of whether this study will be practice-changing," he says. "We found low dose PPI therapy isn't as effective as , so the results could alter their use."

But there are other questions remaining. How long do patients need to take these drugs for them to have a beneficial effect? Who is most likely to benefit from taking them? And importantly, can they prevent deaths specifically from ?

These will be the focus of future research. And Jankowski says the researchers are already drawing up plans to extend the study and begin answering these questions. With that clarity, hopefully this work can begin making an impact on people's lives.

Explore further: Test could diagnose oesophageal cancer 8 years earlier

Related Stories

Test could diagnose oesophageal cancer 8 years earlier

November 6, 2017
A new genetic test could help diagnose oesophageal cancer up to 8 years before symptoms appear in people at a high risk of the disease, according to new research presented at the National Cancer Research Institute's (NCRI) ...

Infrared light to detect early signs of esophageal cancer

September 6, 2016
Scientists have developed an endoscope that uses near-infrared light to spot early warning signs of oesophageal - food pipe - cancer, according to research published in the Journal of Biomedical Optics today.

Swallowing a sponge on a string could replace endoscopy as pre-cancer test

November 3, 2014
Swallowing a sponge on a string could replace traditional endoscopy as an equally effective but less invasive way of diagnosing a condition that can be a forerunner of oesophageal cancer.

Trial to test for Barrett's oesophagus launches in GP surgeries across the UK

March 28, 2017
A Cancer Research UK-funded trial allowing GP surgeries to test for Barrett's oesophagus – a condition that can increase the risk of developing oesophageal cancer – launches in the UK today.

High-fat diet hurts the microbiota in the oesophagus

April 3, 2017
UNSW researchers have observed how microbiota in the oesophagus is affected by a high-fat diet, depleting known beneficial bacteria and increasing the levels of "bad" bacteria.

Sponge on a string test could replace endoscopies

November 10, 2016
Cancer Research UK-funded scientists have discovered that a 'sponge on a string' pill test can identify which people with a condition called Barrett's oesophagus have a low risk of developing oesophageal cancer - sparing ...

Recommended for you

Non-coding DNA reveals a route by which advanced prostate cancer resists treatment

June 15, 2018
Two research teams converge on epigenetic switches that feed treatment-resistant metastatic prostate tumors. This research highlights the value of exploring gene regulation and large-scale structural changes in the cancer ...

Researchers peer inside cells to spy on cancer's on-off switch

June 15, 2018
Forty years after researchers first discovered it in fruit flies, a once-obscure cluster of proteins called PRC2 has become a key target for new cancer-fighting drugs, due to its tendency—when mutated—to bind to and silence ...

PIM-2 protein kinase regulates T-cell activity differently than PIM-1 or PIM-3 isoform

June 15, 2018
The PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity, while PIM-1 and PIM-3 are positive regulators, report Medical University of South Carolina (MUSC) investigators in an article ...

Gene testing could identify men with prostate cancer who may benefit from immunotherapy

June 14, 2018
Scientists have identified a pattern of genetic changes that could pick out men with advanced prostate cancer who are likely to benefit from immunotherapy.

Without 'yoga and chardonnay' leukemia stem cells are stressed to death

June 14, 2018
Change is stressful. The change that a healthy blood stem cell undergoes to become a leukemia stem cell (LSC) is no exception—think of healthy blood stem cells as young professionals and the transformation into an LSC as ...

Statins found to enhance efficacy of chemotherapy drug in blood cancers

June 14, 2018
A team of researchers with members affiliated with several institutions in the U.S. has found that some statins could enhance the efficacy of a chemotherapy drug used to fight blood cancers in mouse models. In their paper ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.